This review provides an overview of novel insights in the clinical management of patients with Multiple Endocrine Neoplasia Type 1, focusing on the last decade since the last update …
S Jha, WF Simonds - Endocrine Reviews, 2023 - academic.oup.com
Recent data suggest an increase in the overall incidence of parathyroid disorders, with primary hyperparathyroidism (PHPT) being the most prevalent parathyroid disorder. PHPT is …
P Goudet, G Cadiot, A Barlier, E Baudin… - Annales d' …, 2024 - Elsevier
Guidelines French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d'étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne …
MFM Van Den Broek, JM De Laat… - The Journal of …, 2021 - academic.oup.com
Introduction Multiple endocrine neoplasia type 1 (MEN1)-related neuroendocrine tumors (NETs) of the lung are mostly indolent, with a good prognosis. Nevertheless, cases of …
A Sada, EB Habermann, TS Yamashita… - Journal of the …, 2022 - journals.lww.com
BACKGROUND: The differences between sporadic and multiple endocrine neoplasia type 1 (MEN-1)–associated insulinoma are not well described. Herein, we compared …
CRC Pieterman, S Grozinsky‐Glasberg… - Journal of …, 2024 - Wiley Online Library
Abstract Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time …
L Das, P Dutta - Best Practice & Research Clinical Endocrinology & …, 2025 - Elsevier
The co-occurrence of primary hyperparathyroidism (PHPT) and pituitary adenomas (PAs) is often indicative of underlying genetic syndromes such as Multiple Endocrine Neoplasia type …
ABSTRACT Multiple Endocrine Neoplasia Type 1 (MEN1) is a rare autosomal dominantly inherited endocrine tumor predisposition syndrome, caused by mutations in the MEN1 gene …
Background Protein-truncating germline pathogenic variants in the N-and C-terminal exons (2, 9, and 10) of the MEN1 gene may be associated with aggressive pancreatic …